Cowen Prime Advisors LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Cowen Prime Advisors LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2023$3,380,410
+156690.8%
3,073,100
+4.1%
1.16%
+34.9%
Q1 2023$2,156
-66.4%
2,953,100
-31.5%
0.86%
-67.4%
Q4 2022$6,425
-99.9%
4,312,400
+34.4%
2.64%
-12.0%
Q3 2022$5,231,000
+103.8%
3,209,400
-0.6%
3.00%
+105.5%
Q2 2022$2,567,000
-65.7%
3,229,500
-22.4%
1.46%
-53.6%
Q1 2022$7,493,000
+4.2%
4,162,500
-1.0%
3.15%
+29.0%
Q4 2021$7,189,000
+0.6%
4,204,000
+21.2%
2.44%
-8.0%
Q3 2021$7,143,000
+11.9%
3,467,600
+25.5%
2.66%
+14.8%
Q2 2021$6,383,000
+148.7%
2,763,400
-14.4%
2.32%
+58.3%
Q2 2020$2,567,0003,229,5001.46%
Other shareholders
RECRO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders